Polypill cuts CVD risk by one-third
Largest trial to date shows four in one pill effective for primary prevention: study
A polypill combining four cardiovascular drugs cut the risk of major cardiovascular events by a third over five years, a Lancet study finds.
The study looked at the effectiveness of the four-in-one pill in primary and secondary prevention of CVD in rural Iran.
